Literature DB >> 21193970

Spectrum of kawasaki disease.

Megha Consul1, Smita Mishra, Arvind Taneja.   

Abstract

The authors report 22 patients of Kawasaki disease, diagnosed and treated over a period of 3 years at a tertiary care centre in New Delhi. Ten cases fullfiled the criteria of a "classical" case while 12 cases were "incomplete" cases. Echocardiography was performed in all cases and coronary artery involvement was found in 8 (36%) cases. All cases received high dose Intravenous Immunoglobulins (IVIG) as standard therapy. In two cases, a repeat dose of IVIG was required for defervescence to occur. All cases recovered after therapy. Those with coronary artery involvement were planned for a 2 years follow up from the time of diagnosis.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21193970     DOI： 10.1007/s12098-010-0356-y

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


  9 in total

1.  Coronary artery dimensions may be misclassified as normal in Kawasaki disease.

Authors:  A de Zorzi; S D Colan; K Gauvreau; A L Baker; R P Sundel; J W Newburger
Journal:  J Pediatr       Date:  1998-08       Impact factor: 4.406

2.  Kawasaki disease--call for a national registry for India.

Authors:  Raju Khubchandani
Journal:  Indian Pediatr       Date:  2010-02       Impact factor: 1.411

3.  A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan.

Authors:  T Kawasaki; F Kosaki; S Okawa; I Shigematsu; H Yanagawa
Journal:  Pediatrics       Date:  1974-09       Impact factor: 7.124

4.  Muco cutaneous lymph node syndrome: (case report).

Authors:  A Taneja; U Saxena
Journal:  Indian Pediatr       Date:  1977-11       Impact factor: 1.411

5.  Coronary diameter in normal infants, children and patients with Kawasaki disease.

Authors:  Shunji Kurotobi; Toshisaburo Nagai; Nobuhiro Kawakami; Tetsuya Sano
Journal:  Pediatr Int       Date:  2002-02       Impact factor: 1.524

6.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Circulation       Date:  2004-10-26       Impact factor: 29.690

7.  Atypical and incomplete Kawasaki disease.

Authors:  R Cimaz; R Sundel
Journal:  Best Pract Res Clin Rheumatol       Date:  2009-10       Impact factor: 4.098

8.  Prevention of giant coronary artery aneurysms in Kawasaki disease by intravenous gamma globulin therapy.

Authors:  A H Rowley; C E Duffy; S T Shulman
Journal:  J Pediatr       Date:  1988-08       Impact factor: 4.406

9.  The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment.

Authors:  K Durongpisitkul; V J Gururaj; J M Park; C F Martin
Journal:  Pediatrics       Date:  1995-12       Impact factor: 7.124
  9 in total
  2 in total

1.  Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: a meta-analysis.

Authors:  Kee-Soo Ha; GiYoung Jang; JungHwa Lee; KwangChul Lee; YoungSook Hong; ChangSung Son; JooWon Lee
Journal:  Eur J Pediatr       Date:  2012-11-16       Impact factor: 3.183

2.  Erythema multiforme as first sign of incomplete Kawasaki disease.

Authors:  Francesco Vierucci; Cristina Tuoni; Francesca Moscuzza; Giuseppe Saggese; Rita Consolini
Journal:  Ital J Pediatr       Date:  2013-02-13       Impact factor: 2.638
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.